Genic Co. Ltd (123330) - Total Liabilities
Based on the latest financial reports, Genic Co. Ltd (123330) has total liabilities worth ₩22.34 Billion KRW (≈ $15.14 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Genic Co. Ltd (123330) equity growth momentum to track the company's year-over-year net asset growth rate.
Genic Co. Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Genic Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Genic Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Genic Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Genic Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Silicon Optronics Inc
TW:3530
|
Taiwan | NT$215.53 Million |
|
Finbar Group Ltd
AU:FRI
|
Australia | AU$74.71 Million |
|
Song Hong Garment JSC
VN:MSH
|
Vietnam | ₫2.46 Trillion |
|
AJ Networks Co Ltd
KO:095570
|
Korea | ₩1.29 Trillion |
|
OFX Group Ltd
AU:OFX
|
Australia | AU$514.38 Million |
|
Cystech Electronics Corp
TWO:6651
|
Taiwan | NT$352.87 Million |
|
Thailand Prime Property Freehold and Leasehold Real Estate Investment Trust
BK:TPRIME
|
Thailand | ฿2.70 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Genic Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Genic Co. Ltd market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genic Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genic Co. Ltd (2012–2025)
The table below shows the annual total liabilities of Genic Co. Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩15.49 Billion ≈ $10.49 Million |
-3.23% |
| 2024-12-31 | ₩16.00 Billion ≈ $10.84 Million |
+34.81% |
| 2023-12-31 | ₩11.87 Billion ≈ $8.04 Million |
-17.64% |
| 2022-12-31 | ₩14.41 Billion ≈ $9.77 Million |
-44.80% |
| 2021-12-31 | ₩26.11 Billion ≈ $17.70 Million |
-5.95% |
| 2020-12-31 | ₩27.77 Billion ≈ $18.82 Million |
-10.46% |
| 2019-12-31 | ₩31.01 Billion ≈ $21.01 Million |
-9.78% |
| 2018-12-31 | ₩34.37 Billion ≈ $23.29 Million |
-12.11% |
| 2017-12-31 | ₩39.11 Billion ≈ $26.50 Million |
-1.32% |
| 2016-12-31 | ₩39.63 Billion ≈ $26.86 Million |
+36.81% |
| 2015-12-31 | ₩28.97 Billion ≈ $19.63 Million |
+42.39% |
| 2014-12-31 | ₩20.34 Billion ≈ $13.79 Million |
+73.85% |
| 2013-12-31 | ₩11.70 Billion ≈ $7.93 Million |
+62.52% |
| 2012-12-31 | ₩7.20 Billion ≈ $4.88 Million |
-- |
About Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more